Welcome to the Anteo Diagnostics Limited (ASX:ADO) Investor Centre. This section is designed to give current and potential investors access to our important public information.
We invite you to browse through our Investor Centre. If you don’t find the information you’re seeking, please contact us.
Anteo Diagnostics is an Australian publicly traded company listed on the Australian Securities Exchange (ASX) under the ticker ADO.
Anteo has developed a proprietary surface coating product called Mix&Go which has broad applicability in diagnostics and in the life sciences industries. Mix&Go enables a researcher to attach a fragile biomolecule such as a protein to a surface without causing damage. This characteristics makes it possible to develop better diagnostic tests, faster and cheaper than possible with conventional methods.
Anteo licenses its Mix&Go product to companies who incorporate it into a broad range of tests, called “bioassays” or “assays”. They benefit because their tests show superior performance while reducing cost of goods.
Mix&Go has substantial additional opportunities in areas such as medical devices and drug delivery as well as in applications in other industries such as Resources and Cleantech which Anteo Dx can either pursue itself or license to other companies.
If you would like to subscribe to ASX announcements for Anteo Diagnostics, please register your email in the field below.
ABN 14 003 209 836
Level 7, 207 Kent St
Sydney NSW 2000